OPSIDIO, LLC
BRYN MAWR, PA · CIK 0001715677 · Biotech · Acquired
Monoclonal antibody targeting disease-associated Stem Cell Factor (SCF248) to prevent and treat chronic kidney disease
- Grants
- $217K
- 1 award
- Sector median: 1
- Raised
- $800K
- 1 Form D · Oct 2017
- 108 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 12
- 2 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Therapeutic Mabs for Chronic Kidney Disease | $217,446 | |
| Private capital raised | Form D · SEC | $800,165 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1767 | SegueTX-Pancreatic Cancer, L.L.C. | — | — |
| 1768 | Abfero Pharmaceuticals, Inc. | — | $1.5M |
| 1769 | CARTHRONIX, INC. | — | — |
| 1770 | OPSIDIO, LLC | — | $800K |
| 1771 | Bedrocan Internatioinal, Inc. | — | $200K |
| 1772 | Deep Longevity | — | — |
| 1773 | Cell-free Bioinnovation Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Alan CasnoffDirector
- Nicholas LukacsDirector
- Frank MarcouxDirector
- Martin PhillipsDirector · Executive Officer
Patents
- ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF BLOCKING THE INTERACTION BETWEEN SCF AND c-KITgranted
- Stem Cell Factor Antibodies And Methods Of Use Thereofapplication
- ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF BLOCKING THE INTERACTION BETWEEN SCF AND c-KITgranted
- Anti-stem Cell Factor Antibodies And Methods Of Use Thereofapplication
- Anti-stem Cell Factor Antibodies And Methods Of Use Thereofapplication
- Anti-stem Cell Factor Antibodies And Methods Of Use Thereof In Renal Diseaseapplication
- Anti-stem Cell Factor Antibodies And Methods Of Use Thereofapplication
- Anti-stem Cell Factor Antibodies And Methods Of Use Thereofapplication
- Stem Cell Factor Antibodies And Methods Of Use Thereofapplication
- Anti-stem Cell Factor Antibodies And Methods Of Use Thereof In Renal Diseaseapplication
- Anti-stem Cell Factor Antibodies And Methods Of Use Thereofapplication
- Stem Cell Factor Antibodies And Methods Of Use Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.